Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion.
about
Adjunct primer for the use of national comprehensive cancer network guidelines for the surgical management of cutaneous malignant melanoma patientsRegional therapies for in-transit diseaseMicrodialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignanciesTranslational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogsTreatment options for limited or symptomatic metastatic melanoma.Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery.Therapy for unresectable recurrent and in-transit extremity melanoma.Isolated limb perfusion for melanoma.Current treatment of locoregional recurrence of melanoma.Isolated limb infusion: Efficacy, toxicity and an evolution in the management of in-transit melanoma.Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal modelResection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma.Isolated limb infusion in a series of over 100 infusions: a single-center experience.The use of isolated limb infusion in limb threatening extremity sarcomasLimb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasmsIsolated limb infusion chemotherapy with or without hemofiltration for recurrent limb melanomaProspective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis.Current surgical management of melanoma.Bevacizumab-induced alterations in vascular permeability and drug delivery: a novel approach to augment regional chemotherapy for in-transit melanoma.Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology.p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumorsIsolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit.History of regional chemotherapy for cancer of the extremities.Current status of hyperthermic limb perfusion for in-transit melanoma.Pharmacokinetics & drug resistance of melphalan in regional chemotherapy: ILP versus ILI.Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma.Future directions in regional treatment strategies for melanoma and sarcoma.Surgery and radiotherapy in the treatment of cutaneous melanomaOptimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?Quality of life after isolated limb infusion for in-transit melanoma of the extremity.Predicting disease progression after regional therapy for in-transit melanoma.Optimizing regional infusion treatment strategies for melanoma of the extremitiesPharmacotherapy of regional melanoma therapy.Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity.Regional treatment strategies for in-transit melanoma metastasis.Isolated limb infusion: technical aspects.Intra-lesional interleukin-2 therapy for in transit melanoma.Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma.
P2860
Q27025460-434279AA-9EC1-464A-8784-47D1EE95F237Q28087553-F5025D29-53B2-47BD-85AA-395BC4D735A6Q28344330-A475E258-BC5A-4569-8518-1FCA92F9C3B1Q30891500-30682842-DA25-405C-9FC7-6F653389137CQ31161199-EBAB186A-C283-43A7-8817-346D9C9D548FQ33263624-E822BC05-8E2B-4A3A-8566-58A2515C15BDQ33348506-3F6A3B38-077C-4A43-9E81-B4B640B19B05Q34580517-CA0761B0-76BD-4F1A-ABA9-B66C3D7B6CD7Q34888462-8D930E4F-ECCB-4BE3-BA13-7DD222E162C4Q35189712-BF88E514-27AC-4533-972B-581DD949E660Q35646297-62B72BF0-87E3-42C4-9919-60852C51522FQ35847459-A924DC3E-4412-4B7A-A3E8-2086ECB9E176Q35857551-924D2634-A037-4AF5-AD54-E8AD1D5B5710Q35857556-DCC6D660-7097-4F88-85E9-EC373CA91FB3Q35871652-3FB0C82B-800A-4E0B-917F-59285E9B95F1Q35891783-96E6A8FF-8955-49AB-A1B8-DC08F71F3D8EQ35932694-2FEBF551-B188-41CD-9D10-7AB88295D901Q36343055-3A530032-C429-4DE9-9002-60F1EC86F0B9Q36626177-096555F9-6BDB-4255-AE36-6DA742546078Q36668237-3E8EC9D5-677E-4AA2-B5A5-7BEA4897D9EBQ36744566-F2122683-D36C-4045-BE24-6CA4BA0AFD27Q36783761-0B45D971-8C8D-4AD5-9A12-7FB072F3EDF1Q36944185-794DF8E2-46EA-4535-8DAD-40E3402AF639Q37120289-2D253E98-80B8-42A9-BFAF-E448C065D5DDQ37130233-87B9997C-BE90-43A9-A7FB-AC4D42DF7DD6Q37130240-CEA8AF40-BA61-45B9-BFEA-0C559F0587B3Q37130246-C1CC6A76-1D3F-4E29-80AE-5087D8FD7783Q37130257-07336B39-2ED2-4D4A-8E2C-113D02ED6C97Q37130262-D5768720-2193-418F-8CEB-77DC22996D6CQ37266677-D8B87275-1FFE-413D-9504-EDD80DD89B0BQ37414453-F04EAA9D-68EB-4BA7-9509-774DC0820D9CQ37509676-FF1498EF-3B7E-4EB7-B630-F31A6AF34DD0Q37509683-BDEA0EE1-2C63-4CA8-AD79-7B58E58C765CQ37628698-FF31A2AF-9452-4021-A7B1-6A008778EDECQ37650312-B32A4C1D-DA85-43FA-A0FB-90A0A21ECF85Q37770250-3AD85FB7-497C-4AAD-94D0-5C59A97CA314Q37812815-38DB08C6-D770-4E06-A363-67D25B346063Q38174452-B3EB0696-8C9F-4764-AA73-ED8441D05D32Q38181030-668C94A1-BB19-4FF1-AC65-3AD763EBCA6DQ38534285-DE446EE9-F384-4E02-A98A-38DF33CD15CE
P2860
Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion.
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Isolated limb infusion with cy ...... ve to isolated limb perfusion.
@ast
Isolated limb infusion with cy ...... ve to isolated limb perfusion.
@en
type
label
Isolated limb infusion with cy ...... ve to isolated limb perfusion.
@ast
Isolated limb infusion with cy ...... ve to isolated limb perfusion.
@en
prefLabel
Isolated limb infusion with cy ...... ve to isolated limb perfusion.
@ast
Isolated limb infusion with cy ...... ve to isolated limb perfusion.
@en
P2093
P2860
P1476
Isolated limb infusion with cy ...... ve to isolated limb perfusion.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1098-2388(199804/05)14:3<238::AID-SSU8>3.0.CO;2-9
P577
1998-04-01T00:00:00Z